Laboratory Corp. (LH) Reports In-Line Q2 EPS; Adjusts Q2 Outlook

Laboratory Corp. (NYSE: LH) reported Q2 EPS of $1.80, in-line with the analyst estimate of $1.80. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.46 billion.

Now sees FY2013 EPS of $6.90 - $7.10, from prior expectations of $6.85 - $7.15 and the consensus of $7.09.

For earnings history and earnings-related data on Laboratory Corp. (LH) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
• Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
• Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance